Clinical evaluation of 3Mix and Vitapex® as treatment options for pulpally involved primary molars

Objective. The aim of this study was to compare the clinical and radiographic success of 3Mix and Vitapex (R) for root canal treatment of pulpally involved primary molars. Methods. Fifty teeth from 37 healthy children aged 3-8 years with pulpally involved primary molars needing root canal procedures were treated with 3Mix or Vitapex (R) before restoration with stainless steel crowns. The research employed a prospective single-blinded randomized design. The subjects were followed up clinically and radiographically at 6 and 12 months, respectively. The outcome was compared using a Z-test with a significance level of 0.05. Results. Both groups showed 100% and 96% clinical success at 6 and 12 months, respectively. At 6 months, radiographic success of 3Mix and Vitapex (R) was 84% and 80%, respectively, and at 12 months, radiographic success of 3Mix and Vitapex (R) was 76% and 56%, respectively. Considering the radiographic findings at the end of 6 and 12 months, no statistically significant differences were found between the two groups (P = 0.356 and 0.068, respectively). Conclusion. 3Mix and Vitapex (R) can be used as a root canal treatment agent in pulpally involved primary teeth.